Suggested Dosing
No typical dosage recommendations
Classical dosage of the leaf was 2 g
Suggested Uses
headache, bedwetting, depression, nervous dyspepsia, atonic constipation, for prophylaxis and treatment of sexual disturbances, strengthening and stimulation during exertion, boosting and maintaining mental and physical capacity, and as an aphrodisiac
Efficacy
Insufficient reliable information to rate efficacy
Interactions
Interaction Checker
No Results
Contraindicated
Serious - Use Alternative
Significant - Monitor Closely
Minor
Contraindicated (0)
Serious - Use Alternative (0)
Monitor Closely (0)
Minor (23)
- acarbose
damiana decreases effects of acarbose by pharmacodynamic antagonism. Minor/Significance Unknown. Theoretical interaction.
- chlorpropamide
damiana decreases effects of chlorpropamide by pharmacodynamic antagonism. Minor/Significance Unknown. Theoretical interaction.
- glimepiride
damiana decreases effects of glimepiride by pharmacodynamic antagonism. Minor/Significance Unknown. Theoretical interaction.
- glipizide
damiana decreases effects of glipizide by pharmacodynamic antagonism. Minor/Significance Unknown. Theoretical interaction.
- glyburide
damiana decreases effects of glyburide by pharmacodynamic antagonism. Minor/Significance Unknown. Theoretical interaction.
- insulin aspart
damiana decreases effects of insulin aspart by pharmacodynamic antagonism. Minor/Significance Unknown. Theoretical interaction.
- insulin detemir
damiana decreases effects of insulin detemir by pharmacodynamic antagonism. Minor/Significance Unknown. Theoretical interaction.
- insulin glargine
damiana decreases effects of insulin glargine by pharmacodynamic antagonism. Minor/Significance Unknown. Theoretical interaction.
- insulin glulisine
damiana decreases effects of insulin glulisine by pharmacodynamic antagonism. Minor/Significance Unknown. Theoretical interaction.
- insulin lispro
damiana decreases effects of insulin lispro by pharmacodynamic antagonism. Minor/Significance Unknown. Theoretical interaction.
- insulin NPH
damiana decreases effects of insulin NPH by pharmacodynamic antagonism. Minor/Significance Unknown. Theoretical interaction.
- insulin regular human
damiana decreases effects of insulin regular human by pharmacodynamic antagonism. Minor/Significance Unknown. Theoretical interaction.
- metformin
damiana decreases effects of metformin by pharmacodynamic antagonism. Minor/Significance Unknown. Theoretical interaction.
- miglitol
damiana decreases effects of miglitol by pharmacodynamic antagonism. Minor/Significance Unknown. Theoretical interaction.
- nateglinide
damiana decreases effects of nateglinide by pharmacodynamic antagonism. Minor/Significance Unknown. Theoretical interaction.
- pioglitazone
damiana decreases effects of pioglitazone by pharmacodynamic antagonism. Minor/Significance Unknown. Theoretical interaction.
- repaglinide
damiana decreases effects of repaglinide by pharmacodynamic antagonism. Minor/Significance Unknown. Theoretical interaction.
- rosiglitazone
damiana decreases effects of rosiglitazone by pharmacodynamic antagonism. Minor/Significance Unknown. Theoretical interaction.
- saxagliptin
damiana decreases effects of saxagliptin by pharmacodynamic antagonism. Minor/Significance Unknown. Theoretical interaction.
- sitagliptin
damiana decreases effects of sitagliptin by pharmacodynamic antagonism. Minor/Significance Unknown. Theoretical interaction.
- tolazamide
damiana decreases effects of tolazamide by pharmacodynamic antagonism. Minor/Significance Unknown. Theoretical interaction.
- tolbutamide
damiana decreases effects of tolbutamide by pharmacodynamic antagonism. Minor/Significance Unknown. Theoretical interaction.
- vildagliptin
damiana decreases effects of vildagliptin by pharmacodynamic antagonism. Minor/Significance Unknown. Theoretical interaction.
Adverse Effects
None reported
Warnings
Contraindications
None reported
Cautions
Excessive doses may cause insomnia & headache
Pregnancy & Lactation
Pregnancy Category: no harmful effects known
Lactation: no harmful effects known
Pregnancy Categories
A: Generally acceptable. Controlled studies in pregnant women show no evidence of fetal risk.
B: May be acceptable. Either animal studies show no risk but human studies not available or animal studies showed minor risks and human studies done and showed no risk. C: Use with caution if benefits outweigh risks. Animal studies show risk and human studies not available or neither animal nor human studies done. D: Use in LIFE-THREATENING emergencies when no safer drug available. Positive evidence of human fetal risk. X: Do not use in pregnancy. Risks involved outweigh potential benefits. Safer alternatives exist. NA: Information not available.Pharmacology
Metabolism: N/A
Excretion: N/A
Mechanism of Action
Reportedly has stimulant, antidepressant, thymoleptic, testosteromimetic, euphoric & nervous restorative properties
